Related Experiment Video

Updated: Aug 15, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

[Myocardial remodeling in chronic renal failure patients on hemodialysis]

A S Sisakian, Ts M Sarkisian, Z A Petrosian

    Klinicheskaia Meditsina
    |October 13, 2005
    PubMed

    Insights

    Chronic renal failure (CRF) patients on hemodialysis often develop left ventricular hypertrophy (LVH). High blood pressure and anemia significantly contribute to cardiac remodeling and reduced ejection fraction in these patients.

    Area of Science:

    • Cardiology
    • Nephrology
    • Pathology

    Context:

    • Pathologic myocardial changes are a leading cause of mortality in end-stage chronic renal failure (CRF).
    • Understanding the impact of CRF on cardiovascular health is crucial for improving patient outcomes.

    Purpose:

    • To investigate the structural and functional myocardial changes in patients with CRF undergoing hemodialysis.
    • To identify the specific factors of CRF that contribute to cardiovascular complications.

    Summary:

    • A positive correlation exists between systolic arterial pressure and left ventricular (LV) remodeling.
    • Anemia severity also correlates positively with LV remodeling in CRF patients on hemodialysis.
    • Concentric LV hypertrophy (LVH) was observed in 65% of patients, while eccentric LVH occurred in 19%.

    Impact:

    • Eccentric LVH with reduced ejection fraction in CRF patients on hemodialysis is linked to elevated systolic and pulse pressure.
    • These findings highlight the importance of managing hypertension and anemia in CRF patients to mitigate cardiac remodeling and improve cardiovascular prognosis.

    More Related Videos

    A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure07:13

    A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

    Published on: April 30, 2020

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    Related Concept Videos

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    Dialysis01:27

    Dialysis

    Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
    Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Renal Failure: Dose Adjustments01:11

    Renal Failure: Dose Adjustments

    In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
    Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
    However, dosage adjustments...